Lev-Ran S - Search Results

1

Neurocognitive functions of heavy cannabis using schizophrenia patients.

Lev-Ran S, Segev A, Braw Y, Levkovitz Y. Lev-Ran S, et al. Eur Psychiatry. 2012 Jul;27(5):365-8. doi: 10.1016/j.eurpsy.2011.04.010. Epub 2011 Jun 24. Eur Psychiatry. 2012. PMID: 21704501

2

Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel.

Shmulewitz D, Eliashar R, Levitin MD, Lev-Ran S. Shmulewitz D, et al. Subst Abuse Treat Prev Policy. 2023 Oct 12;18(1):58. doi: 10.1186/s13011-023-00566-7. Subst Abuse Treat Prev Policy. 2023. PMID: 37828494 Free PMC article.

3

Transcranial magnetic stimulation of the ventromedial prefrontal cortex impairs theory of mind learning.

Lev-Ran S, Shamay-Tsoory SG, Zangen A, Levkovitz Y. Lev-Ran S, et al. Eur Psychiatry. 2012 May;27(4):285-9. doi: 10.1016/j.eurpsy.2010.11.008. Epub 2011 Feb 15. Eur Psychiatry. 2012. PMID: 21324655 Clinical Trial.

4

Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Lev-Ran S, Imtiaz S, Taylor BJ, Shield KD, Rehm J, Le Foll B. Lev-Ran S, et al. Drug Alcohol Depend. 2012 Jun 1;123(1-3):190-200. doi: 10.1016/j.drugalcdep.2011.11.010. Epub 2011 Dec 3. Drug Alcohol Depend. 2012. PMID: 22143039

5

Clinical correlates of cannabis use among adolescent psychiatric inpatients.

Lev-Ran S, Aviram A, Braw Y, Nitzan U, Ratzoni G, Fennig S. Lev-Ran S, et al. Eur Psychiatry. 2012 Aug;27(6):470-5. doi: 10.1016/j.eurpsy.2011.11.002. Epub 2012 Apr 17. Eur Psychiatry. 2012. PMID: 22512931

6

Neurocognitive functioning and cannabis use in schizophrenia.

Segev A, Lev-Ran S. Segev A, et al. Curr Pharm Des. 2012;18(32):4999-5007. doi: 10.2174/138161212802884799. Curr Pharm Des. 2012. PMID: 22716156 Review.

7

Remission of positive symptoms according to the "remission in Schizophrenia Working Group" criteria: a longitudinal study of cognitive functioning.

Braw Y, Sitman R, Cohen M, Berger U, Lev-Ran S, Segev A, Bloch Y, Levkovitz Y. Braw Y, et al. Eur Psychiatry. 2013 Jun;28(5):282-7. doi: 10.1016/j.eurpsy.2012.04.003. Epub 2012 Sep 16. Eur Psychiatry. 2013. PMID: 22989950

8

Cannabis use and mental health-related quality of life among individuals with anxiety disorders.

Lev-Ran S, Le Foll B, McKenzie K, Rehm J. Lev-Ran S, et al. J Anxiety Disord. 2012 Dec;26(8):799-810. doi: 10.1016/j.janxdis.2012.07.002. Epub 2012 Jul 20. J Anxiety Disord. 2012. PMID: 23023160

9

Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates.

Lev-Ran S, Le Foll B, McKenzie K, George TP, Rehm J. Lev-Ran S, et al. Psychiatry Res. 2013 Oct 30;209(3):459-65. doi: 10.1016/j.psychres.2012.12.014. Epub 2013 Jan 10. Psychiatry Res. 2013. PMID: 23312479

10

Rebelliousness in patients suffering from schizophrenia-spectrum disorders--a possible predictor of attitudes towards medication.

Nitzan U, Bukobza G, Aviram S, Fennig S, Lev-Ran S, Braw Y, Bloch Y. Nitzan U, et al. Psychiatry Res. 2013 Oct 30;209(3):297-301. doi: 10.1016/j.psychres.2012.12.028. Epub 2013 Jan 24. Psychiatry Res. 2013. PMID: 23352744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters